ARCHIVES

ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

October 1, 1993

Conversation With The Cancer Letter: Ronald DePinho Says Moon Shots Will Go On

January 18, 2013

DCCP Board Okays Concepts Of New Grants Totaling $1.4 Million Year

February 18, 1983

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

2015 Goal Not a Dream, But a Vision, Director Says

July 18, 2003